Skip to main content
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd. — Investor Relations & Filings

Ticker · MOREPENLAB ISIN · INE083A01026 LEI · 335800OJZDFHFQJ4HP35 BSE.NS Manufacturing
Open in API
Filings indexed 1,660 across all filing types
Latest filing 2023-05-16 Investor Presentation
Country IN India
Listing BSE.NS MOREPENLAB

About Morepen Laboratories Ltd.

https://www.morepen.com

Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.

Recent filings

Filing Released Lang Actions
Investor Presentation
Investor Presentation Classification · 95% confidence The document is titled 'Investors Presentation (Q4’FY23) May, 2023' and is addressed to stock exchanges, indicating it is an official investor communication. It contains detailed financial performance data for the quarter and fiscal year ended 31 March 2023, including consolidated revenues, segment-wise business performance, export revenue, and regulatory approvals. The content is structured as a presentation with charts and business highlights, typical of investor presentations. There is no indication that this is a full annual report, audit report, or earnings release summary. The document is not a brief announcement or a certification but a detailed presentation aimed at investors. Therefore, the appropriate classification is Investor Presentation (IP). The document length (15,000 characters) supports it being a full presentation rather than a short announcement.
2023-05-16 English
Please find enclosed the Investors Presentation (Q4'FY23) May, 2023, based on the financial performance of the company for the quarter and financial year ended 31st March 2023.
Investor Presentation Classification · 95% confidence The document is titled 'Investors Presentation (Q4’FY23) May, 2023' and is addressed to stock exchanges, indicating it is a formal investor communication. It contains detailed financial performance data for the quarter and fiscal year ended 31 March 2023, including revenue growth, segment-wise business breakdown, export revenue, and regulatory approvals. The content is consistent with a presentation format aimed at investors, focusing on financials, strategy, and market position. There is no indication that this is a full annual report, audit report, earnings release summary, or regulatory filing. The document length is substantial (15,000 characters), and it is not merely an announcement of a report. Therefore, the document fits the category of an Investor Presentation (IP).
2023-05-16 English
Financial Result Updates
Regulatory Filings
2023-05-16 English
This is to inform you that the Board of Directors of the company, in their meeting held on Tuesday, 16th May 2023 (commenced at 11.30 A.M. and concluded at 04:15 P.M.), have, inter-alia, ....
Regulatory Filings
2023-05-16 English
Loss of Share Certificates
Regulatory Filings
2023-05-09 English
Pursuant to the Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith ....
Regulatory Filings
2023-05-09 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.